Simon Akerman - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Simon Akerman

Showing results (71-80 of 73) with videos related to

Pageof 8

Sort By:

You have reached the last page of results.This site can display upto 73 results.

Pain|March 7, 2020

PAC1 receptor blockade reduces central nociceptive activity: new approach for primary headache?Jan Hoffmann, Silke Miller, Margarida Martins-Oliveira, et al.

International Journal of Cancer|May 29, 2013

Influence of soluble or matrix-bound isoforms of vascular endothelial growth factor-A on tumor response to vascular-targeted strategiesSimon Akerman, Matthew Fisher, Rachel A Daniel, et al.

Cancer Research|April 3, 2008

Blood vessel maturation and response to vascular-disrupting therapy in single vascular endothelial growth factor-A isoform-producing tumorsGillian M Tozer, Simon Akerman, Neil A Cross, et al.

Pageof 8

Search research articles

Showing results (71-80 of 73) with videos related to

Sort By:

Pageof 8

You have reached the last page of results.This site can display upto 73 results.

Pain|March 7, 2020

PAC1 receptor blockade reduces central nociceptive activity: new approach for primary headache?Jan Hoffmann, Silke Miller, Margarida Martins-Oliveira, et al.

International Journal of Cancer|May 29, 2013

Influence of soluble or matrix-bound isoforms of vascular endothelial growth factor-A on tumor response to vascular-targeted strategiesSimon Akerman, Matthew Fisher, Rachel A Daniel, et al.

Cancer Research|April 3, 2008

Blood vessel maturation and response to vascular-disrupting therapy in single vascular endothelial growth factor-A isoform-producing tumorsGillian M Tozer, Simon Akerman, Neil A Cross, et al.

Pageof 8